Abstract
Recent estimates of the cancer burden in the world indicate that as of the year 2000 10.1 million new cases arise annually. Mortality from cancer accounts for 6.2 million cases. The 5-year prevalence, which estimates the burden of disease that requires care and close surveillance, is estimated at 22.4 million cases worldwide. Incidence reflects, on a broad scale, the impact of the disease as well as the burden of diagnostic and first treatment requirements. Mortality reflects the number of potential years of life lost to cancer and its relation to cancer incidence (i.e., incidence to mortality ratio) and is used as a global index of the diagnostic and therapeutic efficiency of the health system. Currently, the most common cancers in the world are lung cancer (1.2 million new cases), and breast cancer (1 million new cases) followed by colon and rectum combined and stomach cancer (875,000 to 1 million new cases). Cancers of the liver, prostate, and cervix uteri contribute 400–600,000 new cases each. In terms of prevalence, the cancer sites that account for most of the disease burden include the locations with high incidence rates (such as lung cancer) and the relatively less frequent locations for which effective treatments are available, to a substantial fraction of the cases (such as cervix uteri). In these instances, survival of at least 5 years is reasonably good.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
ALTS Study Group (The Atypical Squamous Cell of Undetermined Significance/Low-grade squamous Intraepithelial Lesions Triage Study Group) (2000) Human Papillomavirus Testing for Triage of Women With Cytologic Evidence of Low-Grade Squamous Intraepithelial Lesions: Baseline Data From a Randomized Trial. J Natl Cancer Inst 92(5): 397–402
Beral V, Newton R (1998) Overview of the Epidemiology of Immunodeficiency-Associated Cancers. J Natl Cancer Inst Monogr 23:1–6
Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV, International biological Study on Cervical Cancer (IBSCC) Study Group (1995) Prevalence of Human Papillomavirus Cervical Cancer: a Worldwide Perspective. J Natl Cancer Inst 87(11): 796–802
Bosch FX, Ribes J, Borras J (1999) Epidemiology of Primary Liver Cancer. Semin Liver Dis, 19:271–285
Bosch FX, Rohan T, Schneider A, Frazer I, Pfister H, Castellsagué X, de Sanjosé S, Moreno V, Puig-Tintoré LM, Smith PG, Muñoz N, Zur Hausen H (2001) Papillomavirus research update: highlights of the Barcelona HPV 2000 International Papillomavirus Conference. J Clin Pathol 54(1): 163–175
Bréchot C, Jaffredo F, Lagorce D, Gerken G, Büschenfelde KM, Papakonstontinou A, Hadziyannis S, Romeo R, Colombo M, Rodes J, Bruix J, Williams R, Naoumov N (1998) Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action. J Hepatol 29:173–183.
Brown ML (2000) Helicobacter pylori: Epidemiology and routes of transmission. Epidemiologic Reviews 22:293–297
Cartwright R, Brincker H, Carli PM, Clayden D, Coebergh JW, Jack AD, McNally R, Morgan G, de Sanjosé S, Tumino R, Vornanen M (1999) The rise in incidence of lymphomas in Europe 1985–1992. Eur J Cancer 35:627–633
Castellsagué X, Menéndez C, Loscertales M-P, Kornegay R, dos Santos F, Gomez-Olivé FX, Lloveras B, Abarca N, Vaz N, Barreto A, Bosch FX, Alonso P (2001) Human papillomavirus genotypes in rural Mozambique. Lancet 358:1429
Chang MH, Chen ChJ, Lai MS, Hsu HM, Wu TC, Kong MS, Liang DC, Shau WY, Chen DS (1998) Universal Hepatitis B Vaccination in Taiwan and The Incidence of Hepatocellular Carcioma in Children. New Engl J Med 336(26): 1855–1907
Chin PL, Chu DZ, Clarke KG, Odom-Maryon T, Yen Y, Wagman LD (1999) Ethnic differences in the behavior of hepatocellular carcinoma. Cancer 85:1931–1936.
Corvalan A, Koriyama C, Akiba S, Eizuru Y, Backhouse C, Palma M, Argandona J, Tokunaga M (2001) Epstein-Barr virus in gastric carcinoma is associated with location in the cardia and with a diffuse histology: a study in one area of Chile. Int J Cancer 94(4): 527–530
Dolcetti R, Gloghini A, de Vita S, Vaccher E, de Re V, Tirelli U, Carbone A, Boiocchi M (1995) Characteristics of EBV-infected cells in HIV-related lymphadenopathy: implications for the pathogenesis of EBV-associated and EBV-unrelated lymphomas of HIV-seropositive individuals. Int J Cancer 63:652–659
Domingo-Domenech, E, de Sanjosé S, González Barca E, Romagosa V, Domingo-Clarós A, il-Vernet S, Figueras J, Manito N, Otón B, Petit J, Grañena A, Fernandez de Sevilla A (2001) Post-transplant lymphomas: a 20-year epidemiologic, clinical and pathologic study in a single center. Haematologica 86:715–721
Donato F, Boffetta P, Puoti M (1998) A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 75:347–354
Fortuin M, Chotard J, Jack AD, Maine NP, Mendy M, Hall AJ, Inskip HM, Ceorge MO, Whittle HC (1993) Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation. Lancet 341:1129–31
Franceschi S, Dal Maso L, Arniani S, Crosignani P, Vercelli M, Simonato L, Falcini F, Zanetti R, Barchielli A, Serraino D, Rezza G for the Cancer and AIDS Registry Linkage Study (1998) Br J Cancer 78(7): 966–970
Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, El-Khoby T, Abdel Wahab Y, Aly Ohn ES, Anwar W, Sallam I (2000) The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355: 887–891
Frisch M, Goodman MT (2000) Human Papilllomavirus-associated carcinomas in Hawaii and the Mainland U.S. Cancer 88:1464–1469
Fruchter RG, Maiman M, Arrastia CD, Matthews R, Gates EJ, Holcomb K (1998) Is HIV infection a risk factor for advanced cervical cancer? J Acquir Immune Defic Syndr Hum Retrovirol 18(3):241–5
Goedert JJ ed. (2000) Infectious Causes of Cancer. Targets for Intervention. Humana Press, New Jersey
Gonzalez A, Esteban JI, Madoz P, Viladomiu L, Genesca J, Muniz E, Enriquez J, Torras X, Hernandez JM, Quer J, et al. (1995) Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion-associated hepatitis: final report of a prospective trial. Hepaology 22:439–445
Goodman KJ, Cockburn M (2001) The role of epidemiology in understanding the health effects of Helicobacter pylori. Epidemiology 12:266–271
Hagan H, Jarlais DC, Friedman SR, Purchase D, Alter MJ (1995) Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J Public Health 85:1531–1537
Hagan H, McGough JP,Thiede H, Weiss NS, Hopkins S, Alexander ER (1999) Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol 149(3):203–313.
Hartge P, Devesa SS, Fraumeni Jr. J F (1994) Hodgkin’s and Non-Hodgkin’s Lymphomas. Cancer Surv 19/20:423–453
Helicobacter and Cancer Collaborative Group (2001) Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 49:347–353
Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, Balmaceda I, Greenberg MD, Alfaro M, Burk RD, Wacholder S, Plummer M, Schiffman M (2000) Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica. J Natl Cancer Inst 92(6): 464–474
Hildesheim A, Schiffman M, Bromley C, Wacholder S, Herrero R, Rodriguez AC, Bratti MC, Sherman ME, Scarpidis U, Lin QQ, Terai M, Bromley RL, Buetow K, Apple RJ, Burk RD (2001) Human Papillomavirus Type 16 Variants and Risk of Cervical Cancer. J Natl Cancer Inst 93(4): 315–318
Holly EA, Ralston ML, Darragh TM, Greenblatt RM, Jay N, Palefsky JM (2001) Prevalence and Risk Factors for Anal Squamous Intraepithelial Lesions in Women. J Natl Cancer Inst 93(11): 843–849
IARC (1992) The Epidemiology of Cervical Cancer and Human Papillomavirus. Muñoz N, Bosch FX, Shah KV, Meheus A eds. Vol. 119. IARC Scientific Publications, International Agency for Research on Cancer, Lyon
IARC (1994) Hepatitis Viruses. IARC Monographs on the evaluation of carcinogenic risks to humans. Vol. 59. IARC Scientific Publications, International Agency for Research on Cancer, Lyon
IARC (1995) Human Papillomaviruses. Vol. 64. IARC monographs on the evaluation of carcinogenic risks to humans, IARC Scientific Publications, International Agency for Research on Cancer, Lyon
IARC (1996) Human Immunodeficiency Viruses and Human T-cell Lymphotropic Viruses. Vol. 67. IARC monographs on the evaluation of carcinogenic risks to humans, International Agency for Research on Cancer, Lyon
IARC (1997) Epstein-Barr virus and Kaposi’s sarcoma Herpesvirus/Human Herpesvirus 8 Vol. 70. IARC monographs on the evaluation of carcinogenic risks to humans, International Agency for Research on Cancer, Lyon
Jaffe E, Lee Harris N, Stein H, Vardiman JW (2001) Pathology & Genetics. Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon
Kjaer SK, Van der Brule AJC, Boch JE, Poll PA, Poll PA, Sherman ME, Walboomers JMM, Meijer CJLM (1996) Human papillomavirus-the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer 65,601–606
Lee MS, Kim DH, Kim H, Lee HS, Kim CY, Park TS, Yoo KY, Park BJ, Ahn YO (1998) Hepatitis B vaccination and reduced risk of primary liver cancer among male adults: a cohort study in Korea. Int J Epidemiol 27(2):316–319
Levine AM, Shibata D, Sullivan-Halley J, Nathwani B, Brynes R, Slovak, ML, Mahterian S, Lynn Riley C, Weiss L, Levine PH, Rasheed S, Bernstein L (1992) Epidemiological and biological study of acquired immunodeficiency syndrome-related lymphoma in the country of Los Angeles: preliminary results. Cancer Research 52:5482–5484
Li Y, Law M, McDonald A, Correll P, Kaldor JM, Grulich AE (2002) Estimation of Risk of Cancers before Occurrence of Acquired Immunodeficiency Syndrome in Persons Infected with Human Immunodeficiency Virus. Am J Epidemiol 155(2): 153–158
Liaw KL, Hsing AW, Chen C-J, Schiffman MH, Zhang TY, Hsieh CY, Greer CE, You SL, Huang TW, Wu TC, O’Leary TJ, Seidman JD, Blot WJ, Meinert CL and Manos MM (1995) Human papillomavirus and cervical neoplasia: a case-control study in Taiwan Int J Cancer 62:565–571
Logan RP, Walker MM (2001) ABC of the upper gastrointestinal tract: Epidemiology and diagnosis of Helicobacter pylori infection. BMJ 323(7318): 920–922
Mazzaro C, Zagonel V, Monfardini S, Tulissi P, Pussini E, Fanni M, Sorio R, Bortolus R, Crovatto M, Santini G, Tiribelli C, Sasso F, Masutti R, Pozzato G (1996) Hepatitis C virus and non-Hodgkin’s lymphomas. Br J Haematol 77(12):2604–2613
Melbye M, Palefsky JM, Gonzales J, Ryder LP, Nielsen H, Bergmann O, Pindborg J, Biggar RJ. (1990) Inmune status as a determinant of human papillomavirus detection and its association with anal epithelial abnormalities. Int J Cancer 46:203–206
Moreno V, Muñoz N, Bosch FX, De Sanjosé S, Gonzalez LC, Tafur L, Gili M, Izarzugaza I, Navarro C, Vergara A, Viladiu P, Ascunce N and Shah K (1995) Risk factors for progression of cervical intraepithelial neoplasm grade III to invasive cervical cancer. Cancer Epidemiol Biomark Prev 4:459–467
Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk BF, Vogelman J (1989) Hodgkin’s disease and Epstein Barr virus. Altered antibody pattern before diagnosis. N Engl J Med 320:689–695
NIH Consensus Development Panel (1996) National Institutes of Health Consensus Development Conference Statement: Cervical Cancer, April 1–3, 1996 J Natl Cancer Inst Monographs 21:7–13
Newton R, Beral V, Weiss RA, Tooze J ed. (1999) Infections and Human Cancer. Vol. 33 Cancer Surveys. Cold Spring Harbor Laboratory Press, USA
Okuda K (1991) Hepatitis C Virus and Hepatocellular Carcinoma. In: Tabor E, di Bisceglie AM, Purcell RH (Eds.) Etiology, pathology, and treatment of hepatocellular carcinoma in North America. Chapter 9. PPC — Gulf Publishing Company, Houston, pp. 119–126.
Palefsky J (1994) Anal human papillomavirus infection and cancer in HIV-positive individuals. An emerging problem. AIDS 8:295
Palefsky M (2000) Anal squamous intraepithelial lesions in human immunodeficiency virus-positive men and women. Semin Oncol 27, 471–479
Pallesen G, Hamilton-Dutoit SJ, Zhou B (1993) The association of Epstein-Barr virus (EBV) with T-cell lymphoproliferations and Hosdgkin’s disease: two new developments in the EBV field. Advances in Cancer Research Vol. 62 Academia Press Inc., pp. 179–239
Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (1997) Cancer Incidence in Five Continents. Vol. VII, No: 143. IARC Scientific Publications, Lyon
Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153–156
Parsonnet J., Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelman JH, Friedman GD (1994) Helicobacter pylori infection and gastric lymphoma. New Engl J Med 330:1267–1271
Persing DH, Prendergast FG (1999) Infection, Immunity and Cancer. Arch Pathol Lab Med 123:1015–1022
Price (1990) Immunoproliferative small intestinal disease: a study of 13 cases with alpha heavy-chain disease. Histopathology 17:7–17
Selik RM, Rabkin CS (1998) Cancer death rates associated with human immunodeficiency virus infection in the United States. J Natl Cancer Inst 90(17): 1300–1302
Serraino D, Carrieri P, Pradier, C, Bidoli E, Dorrucci M, Ghetti E, Shiesari A, Zucconi R, Pezzotti P, Dellamonica P, Franceschi S, Rezza G (1999) Risk of invasive cervical cancer among women with, or at risk for, HIV infection. Int J Cancer 82:334–337
Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L, Russo D, Falasca E, Botta GA, Baccarani M (1996) Prevalence of Hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 87:4296–4301
Sitas H, Bezwoda WR, Levin V, Ruff P, Kew MC, Hale MJ, Carrara H, Beral G, Fleming G, Odes R, Weaving A (2000) Association between human immunodeficiency virus type 1 infection and cancer in the black population of Johannesburg and Soweto, South Africa. Br J Cancer 75(11): 1704–1707
Swinnen LJ (2000) Posttransplant Lymphoproliferative Disorder. In: Goedert JJ ed. (2000) Infectious Causes of Cancer. Targets for Intervention. Humana Press, New Jersey pp. 63–76
Tabor E (1999) The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1. Transmission 39:1160–1168
Thomas KK, Hughes JP, Kuypers JM, Kiviat NB, Lee SK, Adam DE, Koutsky LA (2000) Concurrent and sequential acquisition of different genital Human Papillomavirus types. J Infect Dis 182:1097–1102
Tokunaga M, Land CE, Uemura Y, Tokumode T, Tanaka S, Sato E (1993a) Epstein-Barr virus in gastric carcinoma. Am J Pathol 143(5): 1250–1254
Tokunaga M, Uemura Y, Tokudome T, Ishidate T, Masuda H, Ohazaka E, Kaneko K, Naoe S, Ito M, Okamura A et al. (1993b) Epstein-Barr virus related gastric cancer in Japan: a molecular patho-epidemiological study. Acta Pathol Lpn 43(10): 574–581
Vail Mayans M, de Sanjosé S (2000) El cancer de cuello uterino y la influencia del VIH en su desarrollo en mujeres jovénes desfavorecidas socialmente. Med Clin 114: 656–657
van Damme P, Kne MA, Meheus A on behalf of the Viral Hepatitis Prevention Board (1997) Integration of hepatitis B vaccination into national immunisation programmes. BMJ 314:1033–1037
Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ (2001) Helicobacter Pylori infection and the development of gastric cancer. N Engl J Med 345(11): 784–789
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1): 12–19
Whitby D, Lluppi M, Barozzi P, Boshoff C, Weiss RA, Torelli G (1998) Human Herpesvirus 8 Seroprevalence in Blood Donors and Lymphoma Patients From Different Regions of Italy. J Natl Cancer Inst 90:395–397
Zucca E, Roggero E (1996) Biology and treatment of MALT lymphoma: the state-of-the-art in 1996. A workshop at the 6th International Conference on Malignant Lymphoma. Mucosa-Associated Lymphoid Tissue. Ann Oncol 7(8):787–792
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bosch, F.X., de Sanjosé, S., Ribes, J., González, C.A. (2003). Infections and the Etiology of Human Cancer: Epidemiological Evidence and Opportunities for Prevention. In: Vainio, H.U., Hietanen, E.K. (eds) Mechanisms in Carcinogenesis and Cancer Prevention. Handbook of Experimental Pharmacology, vol 156. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-08602-5_13
Download citation
DOI: https://doi.org/10.1007/978-3-662-08602-5_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-07859-0
Online ISBN: 978-3-662-08602-5
eBook Packages: Springer Book Archive